Digital Therapeutics Market to Reach $13.80 Bn, Globally, by 2027

Rise in adoption of smartphones and tablets along with healthcare apps, surge in incidences of chronic diseases, and growth in need to control healthcare costs drive the growth of the global digital therapeutics market. However, lack of awareness regarding digital therapeutics in emerging economies and concerns regarding data privacy hamper the market growth. On the contrary, emerging markets across developing countries are expected to create lucrative opportunities in the future.

Get detailed COVID-19 impact analysis on the Digital Therapeutics Market:
https://www.alliedmarketresearch.com/request-for-customization/2117?reqfor=covid

Major market players

• 2MORROW, Inc.
• Click Therapeutics, Inc.
• Akili Interactive Labs, Inc.
• Happify, Inc.
• Fitbit, Inc. (Twine Health, Inc.)
• Livongo Health, Inc.
• Kaia Health
• Omada Health, Inc.
• Medtronic Plc.
• Proteus Digital Health, Inc.
• Pear Therapeutics, Inc.
• Voluntis, Inc.
• Resmed, Inc. (Propeller Health)
• Welldoc, Inc.

North America held the lion's share

By region, the market across North America held the largest share in 2019, accounting for nearly half of the total revenue. This is owing to increase in the geriatric population, rise in incidence of chronic diseases, surge in demand for wireless & portable systems, and availability of sophisticated reimbursement structure that aims in reducing expenditure. However, the global digital therapeutics market across Asia-Pacific is projected to manifest the highest CAGR of 22.2% during the forecast period, due to increase in smartphone penetration, rise in need to curb healthcare costs, and increase in prevalence of chronic diseases.

Covid-19 scenario:

• The pandemic disrupted the healthcare system across the globe, which increased the demand for apps and services that could help in lifestyle enhancements and medical intervention.
• Since the outbreak of novel coronavirus, there has been a significant increase in awareness regarding the importance of digital health.
• As people are facing unprecedented circumstances, prevalence of mental illness and rate of drug abuse has increased. This has increased demand for digital therapeutics apps and services.

The Digital Therapeutics Market was pegged at $2.88 billion in 2019, and is projected to reach $13.80 billion by 2027, growing at a CAGR of 20.5% from 2020 to 2027. The report provides an extensive analysis of the market dynamics including drivers & restraints, major winning strategies, market size & projections, competitive landscape, and major segments.

Table of Content

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key Market Segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Top player positioning, 2019
3.4.Porter’s five forces analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in adoption of smartphones and tablets, coupled with healthcare apps
3.5.1.2.Growth in need to control healthcare costs
3.5.1.3.Rise in incidences of chronic diseases

3.5.2.Restraints

3.5.2.1.Lack of awareness regarding digital therapeutics in developing countries
3.5.2.2.Patient data privacy concerns

3.5.3.Opportunity

3.5.3.1.Emerging markets offer significant growth opportunities

3.6.Impact analysis of COVID-19 on the digital therapeutics market
3.7.Impact of government regulations on global digital therapeutics market

3.7.1.U.S. FDA’s premarket clearance and approval requirements
3.7.2.European Union premarket clearance and approval requirements
3.7.3.Japan premarket clearance and approval requirements

3.8.Strategy adopted by top 10 start-ups

3.8.1.Meru Health, Inc.
3.8.2.Bold Health Limited
3.8.3.BehaVR, LLC
3.8.4.Naluri Hidup Sdn Bhd
3.8.5.Big Health
3.8.6.Hinge Health, Inc.
3.8.7.Glooko, Inc.
3.8.8.Holmusk Pte. Ltd.
3.8.9.Wellthy Therapeutics Pvt Ltd.
3.8.10.Virta Health Corp.

3.9.Key digital technologies for digital therapeutics

3.9.1.Mobile health (mHealth)
3.9.2.Personalized healthcare
3.9.3.Digital Cognitive Behavior Therapy (CBT)
3.9.4.Wearable devices and sensors

3.10.Necessary human resources required for digital therapeutics development
3.11.Usage of patient data acquired from digital therapeutics

3.11.1.Types of personal information that are collected by DTx companies

CHAPTER 4:DIGITAL THERAPEUTICS MARKET, BY APPLICATION

4.1.Overview

4.1.1.Market size and forecast

4.2.Diabetes

4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Obesity

4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Cardiovascular diseases

4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

4.5.Central nervous system (CNS) diseases

4.5.1.Key market trends and growth opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country

4.6.Gastrointestinal disorder

4.6.1.Key market trends and growth opportunities
4.6.2.Market size and forecast
4.6.3.Market analysis, by country

4.7.Respiratory diseases

4.7.1.Key market trends and growth opportunities
4.7.2.Market size and forecast
4.7.3.Market analysis, by country

4.8.Smoking cessation

4.8.1.Key market trends and growth opportunities
4.8.2.Market size and forecast
4.8.3.Market analysis, by country

4.9.Others

4.9.1.Key market trends and growth opportunities
4.9.2.Market size and forecast
4.9.3.Market analysis, by country

CHAPTER 5:DIGITAL THERAPEUTICS MARKET, BY PRODUCT

5.1.Overview

5.1.1.Market size and forecast

5.2.Software

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Devices

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

CHAPTER 6:DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Business-to-business (B2B)

6.2.1.Market size and forecast, by type

6.2.1.1.Employer

6.2.1.1.1.Market size and forecast

6.2.1.2.Healthcare Providers

6.2.1.2.1.Market size and forecast

6.2.1.3.Others

6.2.1.3.1.Market size and forecast

6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Business-to-consumers

6.3.1.Market size and forecast, by type

6.3.1.1.Patients

6.3.1.1.1.Market size and forecast

6.3.1.2.Caregivers

6.3.1.2.1.Market size and forecast

6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
Read More @ https://www.alliedmarketresearch.com/digital-therapeutics-market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.